Qatar - Sidra Medicine, a member of Qatar Foundation, has established a gene therapy centre to treat rare genetic diseases such as Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD).

Sidra Medicine has become a key player in DMD care in the region. In June 2024, it made history by becoming the first hospital in Qatar and the fifth hospital worldwide to administer Elevidys to a DMD ...

Doha, Qatar: Sidra Medicine celebrated the achievements of 14 middle and senior managers who completed the newly launched Strategic Leadership Development Certificate Program offered by Georgetown ...

Dr Elrishi added that the event also witnessed experts from various institutions, including Hamad Hospital, the Primary Health Care Corporation, Sidra Hospital ... noting that Qatar has a high ...

She is also the founder and CEO of 6M Geriatrics and Hospital Medicine. Sidra Medicine works closely with its academic partner Weill-Cornell Medicine in Qatar, and other health and research ...

Tinubu-Karch joined Sidra Medicine, an entity of the Qatar Foundation, in November 2022. In July 2024, the company signed an MoU with the Children’s National Hospital in Washington D.C. to establish a ...